Literature DB >> 20019244

Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.

Sébastien Anthérieu1, Christophe Chesné, Ruoya Li, Sandrine Camus, Agustin Lahoz, Laura Picazo, Miia Turpeinen, Ari Tolonen, Jouko Uusitalo, Christiane Guguen-Guillouzo, André Guillouzo.   

Abstract

HepaRG cells possess the unique property to differentiate in vitro and to express various functions of mature hepatocytes, including the major cytochromes P450 (P450s). In the present study, we carefully analyzed mRNA expression and activity of the major P450s and their responsiveness to three prototypical inducers, phenobarbital, rifampicin, and omeprazole, in differentiated HepaRG cell cultures over a 4-week period after low and high seeding. Only minor differences were observed in P450 activities when measured by two cocktails of probe substrates, probably related to the choice and/or concentration of substrates. Similar results were obtained from the two cell seeding conditions. Expression and activities of several P450s were dimethyl sulfoxide-dependent. However, basal P450 expression and activities as well as their responsiveness to the prototypical inducers were well maintained over the 4-week period, and a good correlation was observed between transcript levels and corresponding activities. Thus, CYP1A2, CYP2B6, and CYP3A4 were found to accurately respond to their respective prototypical inducers, i.e., omeprazole, phenobarbital, and rifampicin. Likewise, basal expression of several phase II enzymes, transporters, and nuclear receptors, and response to inducers were also well preserved. More genes were found to be induced in HepaRG cells than in primary human hepatocytes, and no marked variation was noticed between the different passages. Taken together, these data support the conclusion that HepaRG cells represent a promising surrogate to primary human hepatocytes for xenobiotic metabolism and toxicity studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019244     DOI: 10.1124/dmd.109.030197

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  68 in total

1.  The Chinese herbal medicine Sophora flavescens activates pregnane X receptor.

Authors:  Laiyou Wang; Feng Li; Jie Lu; Guodong Li; Dan Li; Xiao-bo Zhong; Grace L Guo; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2010-08-24       Impact factor: 3.922

2.  HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity.

Authors:  Mitchell R McGill; Hui-Min Yan; Anup Ramachandran; Gordon J Murray; Douglas E Rollins; Hartmut Jaeschke
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

Review 3.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

Review 4.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.

Authors:  Shyam Sundhar Bale; Laura Moore; Martin Yarmush; Rohit Jindal
Journal:  Tissue Eng Part B Rev       Date:  2016-06-01       Impact factor: 6.389

5.  In vitro profiling of toxic effects of prominent environmental lower-chlorinated PCB congeners linked with endocrine disruption and tumor promotion.

Authors:  Kateřina Pěnčíková; Lucie Svržková; Simona Strapáčová; Jiří Neča; Iveta Bartoňková; Zdeněk Dvořák; Martina Hýžďalová; Jakub Pivnička; Lenka Pálková; Hans-Joachim Lehmler; Xueshu Li; Jan Vondráček; Miroslav Machala
Journal:  Environ Pollut       Date:  2018-03-15       Impact factor: 8.071

6.  Atropisomers of 2,2',3,3',6,6'-hexachlorobiphenyl (PCB 136) exhibit stereoselective effects on activation of nuclear receptors in vitro.

Authors:  Kateřina Pěnčíková; Petra Brenerová; Lucie Svržková; Eva Hrubá; Lenka Pálková; Jan Vondráček; Hans-Joachim Lehmler; Miroslav Machala
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-09       Impact factor: 4.223

Review 7.  Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.

Authors:  Avner Ehrlich; Daniel Duche; Gladys Ouedraogo; Yaakov Nahmias
Journal:  Annu Rev Biomed Eng       Date:  2019-06-04       Impact factor: 9.590

8.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

9.  Impact of iron oxide nanoparticles on xenobiotic metabolism in HepaRG cells.

Authors:  Linn Voss; Kiymet Yilmaz; Lea Burkard; Janja Vidmar; Valerie Stock; Ute Hoffmann; Oliver Pötz; Helen Sophie Hammer; Matthias Peiser; Albert Braeuning; Katrin Löschner; Linda Böhmert; Holger Sieg
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

10.  Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells.

Authors:  Klarissa D Hardy; Michelle D Wahlin; Ioannis Papageorgiou; Jashvant D Unadkat; Allan E Rettie; Sidney D Nelson
Journal:  Drug Metab Dispos       Date:  2013-11-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.